Specific neonatally induced tolerance to Mls locus determinants

Area of Science:

• Immunology
• T cell tolerance
• Alloantigen recognition

Background:

• Neonatal immune tolerance is crucial for preventing autoimmune diseases and graft rejection.
• The Major complex (Mls) locus in mice encodes alloantigens that elicit strong T cell responses.
• Understanding Mls-induced tolerance mechanisms provides insights into broader immune regulation.

Purpose of the Study:

• To investigate the mechanism of specific immune tolerance induced by neonatal exposure to Mls-incompatible spleen cells.
• To determine if tolerance affects T cell proliferation and cytokine production.
• To elucidate the role of clonal deletion or inactivation in Mls tolerance.

Main Methods:

• Neonatal CBA/HT6T6 mice were injected with Mls-incompatible F1 spleen cells.
• Bulk mixed lymphocyte cultures and limiting dilution assays were used to assess T cell responses.
• Interleukin 2 (IL-2) production and cell proliferation were measured.
• Responses to various stimulators (Mlsd, Con A, H-2d, self-Ia) were evaluated.

Main Results:

• Neonatal injection induced specific tolerance to Mlsd alloantigens, abrogating T cell proliferation and IL-2 production.
• A significant decrease (280-fold average) in Mlsd-responsive T cell precursors was observed.
• Tolerance was specific, with unaffected responses to Con A, H-2d, and self-Ia.
• Mechanisms like chimerism or suppressor cells were ruled out.

Conclusions:

• Neonatal Mls-incompatible spleen cell injection induces specific tolerance via clonal deletion or inactivation.
• The Mls locus controls alloantigenic determinants recognized by T cells.
• Responder mice possess specific T cell receptors for Mls determinants.